{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:18:33Z","timestamp":1788290313198,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01585-w","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:02:25Z","timestamp":1788289345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Advanced Lung Cancer Inflammation Index Is Not Independently Prognostic for Overall Survival in De Novo Metastatic Pancreatic Cancer: A Comparison with Established Inflammation- and Nutrition-based Scores"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0865-7835","authenticated-orcid":false,"given":"R\u0131fat Furkan","family":"Ayd\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6590-4444","authenticated-orcid":false,"given":"Elif Berna","family":"K\u00f6ksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"1585_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"1585_CR2","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395:2008\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(20)30974-0.","journal-title":"Lancet"},{"key":"1585_CR3","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M. Pancreatic cancer. Nat Reviews Disease Primers. 2016;2:16022. https:\/\/doi.org\/10.1038\/nrdp.2016.22.","journal-title":"Nat Reviews Disease Primers"},{"key":"1585_CR4","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913\u201321. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155.","journal-title":"Cancer Res"},{"key":"1585_CR5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371:1039\u201349. https:\/\/doi.org\/10.1056\/NEJMra1404198.","journal-title":"N Engl J Med"},{"key":"1585_CR6","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817\u201325. https:\/\/doi.org\/10.1056\/NEJMoa1011923.","journal-title":"N Engl J Med"},{"key":"1585_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3322\/caac.21190","volume":"63","author":"CL Wolfgang","year":"2013","unstructured":"Wolfgang CL, Herman JM, Laheru DA. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318\u201348. https:\/\/doi.org\/10.3322\/caac.21190.","journal-title":"CA Cancer J Clin"},{"key":"1585_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejso.2006.10.004","volume":"33","author":"KS Goonetilleke","year":"2007","unstructured":"Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19\u2009\u2013\u20099) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33:266\u201370. https:\/\/doi.org\/10.1016\/j.ejso.2006.10.004.","journal-title":"Eur J Surg Oncol"},{"key":"1585_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3978\/j.issn.2078-6891.2011.021","volume":"3","author":"UK Ballehaninna","year":"2012","unstructured":"Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19\u2009\u2013\u20099 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal. J Gastrointest Oncol. 2012;3:105\u201319. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2011.021.","journal-title":"J Gastrointest Oncol"},{"key":"1585_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649\u201355. https:\/\/doi.org\/10.1097\/00000421-198212000-00014.","journal-title":"Am J Clin Oncol"},{"key":"1585_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1475-2891-9-69","volume":"9","author":"D Gupta","year":"2010","unstructured":"Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69. https:\/\/doi.org\/10.1186\/1475-2891-9-69.","journal-title":"Nutr J"},{"key":"1585_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47\u201352. https:\/\/doi.org\/10.1038\/nature16965.","journal-title":"Nature"},{"key":"1585_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson EA, Sadanandam A, Olson P. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011;17:500\u20133. https:\/\/doi.org\/10.1038\/nm.2344.","journal-title":"Nat Med"},{"key":"1585_CR14","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1136\/gutjnl-2015-311256","volume":"66","author":"P Martinelli","year":"2017","unstructured":"Martinelli P, Carrillo-de Santa Pau E, Cox T. GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Gut. 2017;66:1665\u201376. https:\/\/doi.org\/10.1136\/gutjnl-2015-311256.","journal-title":"Gut"},{"key":"1585_CR15","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","volume":"467","author":"S Yachida","year":"2010","unstructured":"Yachida S, Jones S, Bozic I. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467:1114\u20137. https:\/\/doi.org\/10.1038\/nature09515.","journal-title":"Nature"},{"key":"1585_CR16","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","volume":"383","author":"DS Hong","year":"2020","unstructured":"Hong DS, Fakih MG, Strickler JH. KRAS(G12C) inhibition with sotorasib in advanced solid tumors. N Engl J Med. 2020;383:1207\u201317. https:\/\/doi.org\/10.1056\/NEJMoa1917239.","journal-title":"N Engl J Med"},{"key":"1585_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"T Golan","year":"2019","unstructured":"Golan T, Hammel P, Reni M. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med. 2019;381:317\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1903387.","journal-title":"N Engl J Med"},{"key":"1585_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357:409\u201313. https:\/\/doi.org\/10.1126\/science.aan6733.","journal-title":"Science"},{"key":"1585_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1471-2407-13-158","volume":"13","author":"SH Jafri","year":"2013","unstructured":"Jafri SH, Shi R, Mills G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer. 2013;13:158. https:\/\/doi.org\/10.1186\/1471-2407-13-158.","journal-title":"BMC Cancer"},{"key":"1585_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/icvts\/ivx329","volume":"26","author":"M Tomita","year":"2018","unstructured":"Tomita M, Ayabe T, Nakamura K. The advanced lung cancer inflammation index is an independent prognostic factor after surgical resection in patients with non-small-cell lung cancer. Interact Cardiovasc Thorac Surg. 2018;26:288\u201392. https:\/\/doi.org\/10.1093\/icvts\/ivx329.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"1585_CR21","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1007\/s00520-020-05979-9","volume":"29","author":"P Gaudioso","year":"2021","unstructured":"Gaudioso P, Borsetto D, Tirelli G. Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study. Support Care Cancer. 2021;29:4683\u201391. https:\/\/doi.org\/10.1007\/s00520-020-05979-9.","journal-title":"Support Care Cancer"},{"key":"1585_CR22","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1097\/DCR.0000000000001658","volume":"63","author":"K Kusunoki","year":"2020","unstructured":"Kusunoki K, Toiyama Y, Okugawa Y. Advanced lung cancer inflammation index predicts outcomes of patients with colorectal cancer after surgical resection. Dis Colon Rectum. 2020;63:1242\u201350. https:\/\/doi.org\/10.1097\/DCR.0000000000001658.","journal-title":"Dis Colon Rectum"},{"key":"1585_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.23922\/jarc.2023-077","volume":"8","author":"T Horino","year":"2024","unstructured":"Horino T, Tokunaga R, Miyamoto Y. Advanced lung cancer inflammation index: a novel comprehensive biomarker of host status for patients with metastatic colorectal cancer. J Anus Rectum Colon. 2024;8:137\u201349. https:\/\/doi.org\/10.23922\/jarc.2023-077.","journal-title":"J Anus Rectum Colon"},{"key":"1585_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12885-023-10570-6","volume":"23","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhao K, Kuang T. The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy. BMC Cancer. 2023;23:101. https:\/\/doi.org\/10.1186\/s12885-023-10570-6.","journal-title":"BMC Cancer"},{"key":"1585_CR25","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.2147\/CMAR.S222297","volume":"11","author":"E Topkan","year":"2019","unstructured":"Topkan E, Mertsoylu H, Ozdemir Y, et al. Prognostic usefulness of advanced lung cancer inflammation index in locally-advanced pancreatic carcinoma patients treated with radical chemoradiotherapy. Cancer Manag Res. 2019;11:8807\u201315. https:\/\/doi.org\/10.2147\/CMAR.S222297.","journal-title":"Cancer Manag Res"},{"key":"1585_CR26","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1002\/cam4.3233","volume":"9","author":"DA Barth","year":"2020","unstructured":"Barth DA, Brenner C, Riedl JM, et al. External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients. Cancer Med. 2020;9:5473\u20139. https:\/\/doi.org\/10.1002\/cam4.3233.","journal-title":"Cancer Med"},{"key":"1585_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","volume":"39","author":"DC McMillan","year":"2013","unstructured":"McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39:534\u201340. https:\/\/doi.org\/10.1016\/j.ctrv.2012.08.003.","journal-title":"Cancer Treat Rev"},{"key":"1585_CR28","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, Seruga B. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124. https:\/\/doi.org\/10.1093\/jnci\/dju124.","journal-title":"J Natl Cancer Inst"},{"key":"1585_CR29","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/bjc.2013.332","volume":"109","author":"M Stotz","year":"2013","unstructured":"Stotz M, Gerger A, Eisner F. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer. 2013;109:416\u201321. https:\/\/doi.org\/10.1038\/bjc.2013.332.","journal-title":"Br J Cancer"},{"key":"1585_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/SLA.0000000000001988","volume":"266","author":"G Gemenetzis","year":"2017","unstructured":"Gemenetzis G, Bagante F, Griffin JF. Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2017;266:339\u201345. https:\/\/doi.org\/10.1097\/SLA.0000000000001988.","journal-title":"Ann Surg"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01585-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01585-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01585-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:02:27Z","timestamp":1788289347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01585-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1585"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01585-w","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Ankara University Faculty of Medicine (Decision No: I04-357-25). Due to the retrospective nature of the study, the requirement for informed consent was waived by the committee.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was waived by the Ethics Committee of Ankara University Faculty of Medicine due to the retrospective nature of this study.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as no individual patient data in any form (including individual details, images, or videos) is presented.","order":3,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this study.","order":4,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"205"}}